FI811889L - Foerfarande foer framstaellning av farmakologiskt aktiva indol- och indolinderivat - Google Patents

Foerfarande foer framstaellning av farmakologiskt aktiva indol- och indolinderivat

Info

Publication number
FI811889L
FI811889L FI811889A FI811889A FI811889L FI 811889 L FI811889 L FI 811889L FI 811889 A FI811889 A FI 811889A FI 811889 A FI811889 A FI 811889A FI 811889 L FI811889 L FI 811889L
Authority
FI
Finland
Prior art keywords
carbon atoms
alkyl
hydrogen
procedure
production
Prior art date
Application number
FI811889A
Other languages
English (en)
Finnish (fi)
Other versions
FI811889A7 (fi
Inventor
Michael John Ashton
Andrew William Bridge
Robert Frederick Chapman
Garry Fenton
Anthony Howard Loveless
David Riddell
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of FI811889A7 publication Critical patent/FI811889A7/fi
Publication of FI811889L publication Critical patent/FI811889L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C07F9/5456—Arylalkanephosphonium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI811889A 1980-06-18 1981-06-16 Foerfarande foer framstaellning av farmakologiskt aktiva indol- och indolinderivat FI811889L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8019948 1980-06-18

Publications (2)

Publication Number Publication Date
FI811889A7 FI811889A7 (fi) 1981-12-19
FI811889L true FI811889L (fi) 1981-12-19

Family

ID=10514138

Family Applications (1)

Application Number Title Priority Date Filing Date
FI811889A FI811889L (fi) 1980-06-18 1981-06-16 Foerfarande foer framstaellning av farmakologiskt aktiva indol- och indolinderivat

Country Status (22)

Country Link
US (1) US4493843A (de)
EP (1) EP0042298B1 (de)
JP (1) JPS5728048A (de)
KR (1) KR850001470B1 (de)
AT (1) ATE9329T1 (de)
AU (1) AU539678B2 (de)
CA (1) CA1149811A (de)
DE (1) DE3165998D1 (de)
DK (1) DK264281A (de)
ES (4) ES8300091A1 (de)
FI (1) FI811889L (de)
GB (1) GB2078736B (de)
GR (1) GR75701B (de)
HK (2) HK92684A (de)
HU (1) HU183480B (de)
IE (1) IE52102B1 (de)
IL (1) IL63110A (de)
MY (2) MY8500975A (de)
NZ (1) NZ197441A (de)
PH (1) PH16357A (de)
SG (2) SG68984G (de)
ZA (1) ZA814057B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6608084B1 (en) 1998-08-26 2003-08-19 Aventis Pharma Ltd. Aza-bicycles which modulate the inhibition of cell adhesion
GB9818641D0 (en) * 1998-08-26 1998-10-21 Rh Ne Poulenc Rorer Limited Chemical compounds
WO2001044184A1 (en) * 1999-12-16 2001-06-21 Eli Lilly And Company Synthesis of indole-containing spla2 inhibitors
US7214831B2 (en) 2002-05-22 2007-05-08 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-chalcogenmethylcarbonyl compounds
JP2007529523A (ja) * 2004-03-15 2007-10-25 イーライ リリー アンド カンパニー 肥満症を治療するためのオピオイド受容体拮抗物質としての４−（５−アミノメチル）−インドール−１−イルメチル）−ベンズアミド誘導体および関連化合物
JP6217561B2 (ja) * 2014-08-21 2017-10-25 信越化学工業株式会社 新規オニウム塩化合物及びレジスト組成物並びにパターン形成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3076814A (en) * 1954-04-28 1963-02-05 Upjohn Co Novel process for the preparation of tryptophols and to novel compounds produced therein
DE2237361A1 (de) * 1972-07-29 1974-02-14 Boehringer Mannheim Gmbh (5-indolyloxy)-essigsaeure-derivate und verfahren zur herstellung derselben
US3901899A (en) * 1973-04-27 1975-08-26 Univ Ohio State Res Found Synthesis of indoles from anilines and intermediates therein
US3992392A (en) * 1973-04-27 1976-11-16 The Ohio State University Research Foundation Synthesis of indoles from anilines and intermediates therein
US3950343A (en) * 1973-11-06 1976-04-13 Ayerst, Mckenna And Harrison Ltd. Pyrroloisoquinoline derivatives
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
DE2909779A1 (de) * 1979-03-13 1980-09-18 Thomae Gmbh Dr K Neue indolderivate, deren herstellung und deren verwendung als arzneimittel

Also Published As

Publication number Publication date
DK264281A (da) 1981-12-19
ES512706A0 (es) 1983-04-01
KR830006205A (ko) 1983-09-20
IE52102B1 (en) 1987-06-24
IL63110A (en) 1986-10-31
JPS5728048A (en) 1982-02-15
EP0042298B1 (de) 1984-09-12
DE3165998D1 (de) 1984-10-18
HK92485A (en) 1985-11-29
ES8303333A1 (es) 1983-02-01
KR850001470B1 (ko) 1985-10-10
ES512704A0 (es) 1983-02-01
ES503097A0 (es) 1982-10-01
HU183480B (en) 1984-05-28
SG68984G (en) 1985-03-15
ES8303332A1 (es) 1983-02-01
MY8600409A (en) 1986-12-31
US4493843A (en) 1985-01-15
AU539678B2 (en) 1984-10-11
AU7186481A (en) 1981-12-24
ATE9329T1 (de) 1984-09-15
IE811344L (en) 1981-12-18
ZA814057B (en) 1982-07-28
ES512705A0 (es) 1983-02-01
EP0042298A1 (de) 1981-12-23
GR75701B (de) 1984-08-02
MY8500975A (en) 1985-12-31
NZ197441A (en) 1984-11-09
GB2078736B (en) 1984-03-07
CA1149811A (en) 1983-07-12
FI811889A7 (fi) 1981-12-19
GB2078736A (en) 1982-01-13
ES8300091A1 (es) 1982-10-01
PH16357A (en) 1983-09-05
HK92684A (en) 1984-11-30
SG73085G (en) 1986-05-02
ES8305327A1 (es) 1983-04-01

Similar Documents

Publication Publication Date Title
FI864527L (fi) Tricyklofoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandning.
SE8003815L (sv) Alkyl-ketohexopyranosid-derivat
ES482010A1 (es) Un metodo de preparacion de compuestos heterociclicos deri- vados de hidantoina.
FI811889L (fi) Foerfarande foer framstaellning av farmakologiskt aktiva indol- och indolinderivat
ATE9790T1 (de) 1,4-naphthochinonderivate und deren verwendung.
DE3372095D1 (en) Novel phenylpiperazine derivatives and process for producing the same
ES464045A1 (es) Un procedimiento para la produccion de una gamma-pirona.
ES447751A1 (es) Procedimiento para preparar derivados de imidazolilquinazo- lina.
ES451067A1 (es) Un procedimiento de preparacion de derivados de fenotiazina.
GR74870B (de)
IE780982L (en) 4-hydroxythiazoline-2-thiones.
SE8004622L (sv) Acylaminobensoesyraderivat
FR2451380B1 (de)
ES424221A2 (es) Procedimiento de preparacion de nuevos oxazino (5,6,e) indoles sustituidos.
PL245632A1 (en) Process for preparing novel heterocyclic compounds
AU558025B2 (en) Dithiino(1,4)(2,3-6)pyrrole derivatives
ES462441A1 (es) Un procedimiento para la preparacion de imidazoles.
ES483138A1 (es) Un procedimiento para la preparacion de derivados de tieno- tiacina

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: MAY & BAKER LIMITED